- Home
- GILD vs PGR Comparison
GILD vs PGR Comparison
Compare GILD & PGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- PGR
- Stock Information
- Founded
- GILD 1987
- PGR 1937
- Country
- GILD United States
- PGR United States
- Employees
- GILD N/A
- PGR N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- PGR Property-Casualty Insurers
- Sector
- GILD Health Care
- PGR Finance
- Exchange
- GILD Nasdaq
- PGR Nasdaq
- Market Cap
- GILD 138.2B
- PGR 165.3B
- IPO Year
- GILD 1992
- PGR N/A
- Fundamental
- Price
- GILD $111.79
- PGR $278.85
- Analyst Decision
- GILD Buy
- PGR Buy
- Analyst Count
- GILD 27
- PGR 16
- Target Price
- GILD $105.32
- PGR $280.25
- AVG Volume (30 Days)
- GILD 10.7M
- PGR 3.5M
- Earning Date
- GILD 04-24-2025
- PGR 04-11-2025
- Dividend Yield
- GILD 2.83%
- PGR 1.76%
- EPS Growth
- GILD N/A
- PGR 118.84
- EPS
- GILD 0.38
- PGR 14.40
- Revenue
- GILD $28,754,000,000.00
- PGR $75,343,000,000.00
- Revenue This Year
- GILD $1.77
- PGR $16.18
- Revenue Next Year
- GILD $3.52
- PGR $11.80
- P/E Ratio
- GILD $294.18
- PGR $19.37
- Revenue Growth
- GILD 6.04
- PGR 21.36
- 52 Week Low
- GILD $62.07
- PGR $201.34
- 52 Week High
- GILD $119.96
- PGR $292.99
- Technical
- Relative Strength Index (RSI)
- GILD 57.43
- PGR 56.19
- Support Level
- GILD $104.70
- PGR $271.00
- Resistance Level
- GILD $107.42
- PGR $277.37
- Average True Range (ATR)
- GILD 2.48
- PGR 6.38
- MACD
- GILD -0.62
- PGR -1.47
- Stochastic Oscillator
- GILD 57.74
- PGR 44.77
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About PGR Progressive Corporation (The)
Progressive underwrites private and commercial auto insurance and specialty lines; it has almost 20 million personal auto policies in force and is one of the largest auto insurers in the United States. Progressive markets its policies through independent insurance agencies in the US and Canada and directly via the internet and telephone. Its premiums are split roughly equally between the agent and the direct channel. The company also offers commercial auto policies and entered homeowners insurance through an acquisition in 2015.